Found 1399 matching trials
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS PHASE2 This study compares the safety and effectiveness of giving rivogenlecleucel...
Show More Location
TriStar Bone Marrow Transplant, LLC
Learn More & Join Trial
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies PHASE1 The primary purpose of this study is to determine the safety and efficacy o...
Show More Location
The Affiliated People's Hospital of Ningbo University
Learn More & Join Trial
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma PHASE1 This is a phase I clinical study to evaluate the safety and efficacy of CAR...
Show More Location
Shandong Second Provincial General Hospital
Learn More & Join Trial
TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors PHASE2 The purpose of this study is to find out if removing a specific type of whi...
Show More Location
Memorial SloanKettering Cancer Center
Learn More & Join Trial
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases PHASE1 The goal of this study is to evaluate the safety and efficacy of CD19 CAR T...
Show More Location
Henan Province Engineering Technology Research Center of Immunological Precision Medicine and Artificial Intelligence Application, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
Learn More & Join Trial
the Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL) PHASE1 The main purpose of this study is to explore the sequential therapeutic eff...
Show More Location
Southwest Hospital of Third Millitary Medical University
Learn More & Join Trial
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia PHASE2 This is an open-label, single-arm, Phase 2 study to evaluate the efficacy a...
Show More Location
The First Hospital of Jilin University
Learn More & Join Trial
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases PHASE1 The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Show More Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Learn More & Join Trial
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies EARLY_PHASE1 A study of CTA30X cell injection in the treatment of relapsed or refractory...
Show More Location
The First Affiliated Hospital,College of Medicine, Zhejiang University
Learn More & Join Trial